1. Home
  2. BRNS

BRNS

Barinthus Biotherapeutics plc

Logo Barinthus Biotherapeutics plc

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Founded: 2016 Country:
United Kingdom
United Kingdom
Employees: 130 City: DIDCOT
Market Cap: 122.2M IPO Year: 2021
Target Price: $8.00 AVG Volume (30 days): 22.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.91 EPS Growth: N/A
52 Week Low/High: $1.64 - $5.10 Next Earning Date: 05-10-2024
Revenue: $802,000 Revenue Growth: -98.21%
Revenue Growth (this year): 58.98% Revenue Growth (next year): 33.33%

Share on Social Networks: